Cross-Border Regulating: US and Canada Complete Their First Joint Device Review

article image

A Medtronic device underwent a “joint” FDA-Health Canada premarket review last year as the first phase of a pilot project that the agencies hope will serve as a platform for a broader global Medical Device Single Review Program.

A global single premarket review for medical devices seemed like a pie-in-the-sky goal a few years ago, but some very tangible steps toward that objective have been taken of late, principally by Health Canada and US FDA. Most notably, the two agencies conducted their first “parallel/joint review” of a device last year and are now looking for more products to take on a premarket harmonization test drive.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: